The University of Chicago Header Logo
Last Name


Search Results to Jason Luke

This is a "connection" page, showing the details of why an item matched the keywords from your search.


One or more keywords matched the following items that are connected to Luke, Jason

Item TypeName
Concept Skin Neoplasms
Academic Article Drug-associated dermatomyositis following ipilimumab therapy: a novel immune-mediated adverse event associated with cytotoxic T-lymphocyte antigen 4 blockade.
Academic Article Ipilimumab for patients with advanced mucosal melanoma.
Academic Article Chemotherapy in the management of advanced cutaneous malignant melanoma.
Academic Article Similar efficacy for phase I trials in comparison with DTIC for advanced malignant melanoma: an analysis of melanoma outcomes in CTEP-sponsored phase I trials 1995-2011.
Academic Article Advances in the systemic treatment of cutaneous sarcomas.
Academic Article Kinase inhibitors and immune check-point blockade for the treatment of metastatic melanoma and advanced cancer: synergistic or antagonistic?
Academic Article Clinical activity of ipilimumab for metastatic uveal melanoma: a retrospective review of the Dana-Farber Cancer Institute, Massachusetts General Hospital, Memorial Sloan-Kettering Cancer Center, and University Hospital of Lausanne experience.
Academic Article Imatinib for melanomas harboring mutationally activated or amplified KIT arising on mucosal, acral, and chronically sun-damaged skin.
Academic Article The efficacy of anti-PD-1 agents in acral and mucosal melanoma.
Academic Article Density of immunogenic antigens does not explain the presence or absence of the T-cell-inflamed tumor microenvironment in melanoma.
Academic Article Targeted agents and immunotherapies: optimizing outcomes in melanoma.
Academic Article The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients.
Academic Article Results from phase II trial of HSP90 inhibitor, STA-9090 (ganetespib), in metastatic uveal melanoma.
Academic Article Isolation and characterization of circulating melanoma cells by size filtration and fluorescent in-situ hybridization.
Academic Article A phase 2 study of glembatumumab vedotin, an antibody-drug conjugate targeting glycoprotein NMB, in patients with advanced melanoma.
Academic Article KEYNOTE-716: Phase III study of adjuvant pembrolizumab versus placebo in resected high-risk stage II melanoma.
Academic Article The newest treatments for uveal melanoma.
Academic Article Considering adjuvant therapy for stage II melanoma.
Academic Article Transcriptional analysis of metastatic uveal melanoma survival nominates NRP1 as a therapeutic target.

Search Criteria
  • Skin Neoplasms